Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00976
Species: Homo sapiens
Position : chr8:129543949-129554294
Year: 2016
Title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: endometrial carcinoma
PMID:  26656844
MONDO: MONDO:0002447
Tissue: endometrium
Tissue Ontology ID: UBERON:0001295
Cell Source: Ishikawa
CVCL ID: CVCL_2529
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Super-enhancer profiling; Chromatin interaction assay; Copy-number-expression association analysis; Endogenous enhancer perturbation
High Throughput Method: H3K27ac ChIP-seq; p300 ChIP-seq; DNase-seq; TCGA copy-number analysis; RNA-seq; ROSE super-enhancer calling
Low Throughput Method: 3C-qPCR; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00939 chr8:129543949-129554294 uterus malignant cell endometrial carcinoma
E_00977 chr8:129543949-129554294 endometrium epithelial cell endometrial carcinoma
E_05249 chr8:129546728-129712179 blood B-lymphoblast/precursor B cell B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer